Blue Jet Healthcare has announced a board meeting scheduled for February 13, 2026, to approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The results will be reviewed by the statutory auditor of the company. Trading window closure remains in effect and will reopen on February 16, 2026.
Board Meeting Announcement
The Board of Directors of Blue Jet Healthcare Limited will convene on February 13, 2026, to review and approve the company’s financial performance.
Financial Results Discussion
The primary agenda of the meeting includes the approval of the unaudited standalone financial results for the quarter and nine-month period ending December 31, 2025. These results will be presented alongside the Limited Review Report provided by the company’s statutory auditor.
Trading Window Closure
As previously announced on December 26, 2025, the trading window for company securities remains closed for designated persons and their immediate relatives. The trading window will reopen 48 hours after the declaration of the financial results, specifically on February 16, 2026.
Source: BSE
